Merck & Co., Inc. (MRK) Balance Sheet
As of 2026-06-30 (10-Q), Merck & Co., Inc. (MRK) reported total assets of $129.8B and shareholders' equity of $41.9B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $6.8B. Long-term debt: $51.1B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MRKMerck & Co., Inc.Follow MRK — free
—
Price chart with a free account
- Market cap
- 358.4B
- P/E TTM
- 115.3
- Dividend yield
- 2.3%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9.31 | 10.90 | 13.53 | 13.45 | 15.62 | 7.44 | 8.52 | 6.52 | 6.09 | 7.97 | 9.68 | 8.05 | 8.10 | 12.69 | 6.84 | 13.24 | 14.57 | 6.85 | |
| Short-term investments | 0.29 | 1.30 | 1.44 | 2.69 | 1.87 | 8.28 | 4.90 | 7.83 | 2.41 | 0.90 | 0.77 | 0.00 | 0.00 | 0.50 | 0.25 | 0.45 | 0.00 | 0.29 | |
| Receivables | 6.60 | 7.34 | 8.26 | 7.67 | 7.18 | 6.63 | 6.48 | 7.02 | 6.87 | 7.07 | 6.78 | 6.80 | 9.23 | 9.45 | 10.35 | 10.28 | 11.78 | 12.56 | |
| Inventory | 8.05 | 5.87 | 6.25 | 6.54 | 6.23 | 5.57 | 4.70 | 4.87 | 5.10 | 5.44 | 5.98 | 5.55 | 5.95 | 5.91 | 6.36 | 6.11 | 6.66 | 6.21 | |
| Current assets | 28.43 | 29.06 | 33.18 | 34.86 | 35.69 | 32.61 | 29.75 | 30.61 | 24.77 | 25.88 | 27.48 | 27.76 | 30.27 | 35.72 | 32.17 | 38.78 | 43.52 | 36.68 | |
| Total assets | 112.31 | 105.78 | 105.13 | 106.13 | 105.65 | 98.17 | 101.68 | 95.38 | 87.87 | 82.64 | 84.40 | 91.59 | 105.69 | 109.16 | 106.68 | 117.11 | 136.87 | 129.80 | |
| Current liabilities | 15.64 | 15.64 | 16.25 | 18.35 | 17.87 | 18.40 | 19.20 | 17.20 | 18.61 | 22.21 | 22.22 | 27.33 | 23.87 | 24.24 | 25.69 | 28.42 | 28.33 | 27.73 | |
| Long-term debt | 16.10 | 15.48 | 15.53 | 16.25 | 20.54 | 18.70 | 23.83 | 24.27 | 21.35 | 19.81 | 22.74 | 25.36 | 30.69 | 28.75 | 33.68 | 34.46 | 46.75 | 51.08 | |
| Short-term debt | 1.38 | 2.40 | 1.99 | 4.32 | 4.52 | 2.70 | 2.58 | 0.57 | 3.06 | 5.31 | 3.61 | 6.43 | 2.41 | 1.95 | 1.37 | 2.65 | 2.59 | 2.83 | |
| Shareholders' equity | 59.06 | 54.38 | 54.52 | 53.02 | 49.77 | 48.65 | 44.68 | 40.09 | 34.34 | 26.70 | 25.91 | 25.32 | 38.18 | 45.99 | 37.58 | 46.31 | 52.61 | 41.93 |
USD billions · SEC XBRL
Merck & Co., Inc. — questions
- How much cash does Merck & Co., Inc. have?
- $6.8B in cash and cash equivalents as of 2026-06-30.
- How much debt does Merck & Co., Inc. have?
- $51.1B of long-term debt and $2.8B due within a year as of 2026-06-30.
- What are Merck & Co., Inc.'s total assets?
- $129.8B as of 2026-06-30.
- What is Merck & Co., Inc.'s shareholders' equity?
- $41.9B as of 2026-06-30.
Every figure on this page comes from Merck & Co., Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.